Section 22-B10833. PLANS FOR REFUNDING THE COST OF ELECTRONIC PRODUCTS

 

10833.1Every plan for refunding the cost of an electronic product shall be submitted to the Department in writing, and in addition to other relevant information which the Department may require, shall include:

 

(a) Identification of the product involved;

 

(b) The approximate number of defective product units which have left the place of manufacture;

 

(c) The manner in which the refund operation will be effected including the procedure for obtaining possession of the product for which the refund is to be made;

 

(d) The steps which the manufacturer will take to ensure that the defective products will not be reintroduced into commerce until it complies with each applicable District standard and has no defect relating to the safety of its use;

 

(e) A time limit, reasonable in light of the circumstances, for obtaining the product and making the refund;

 

(f)A statement that the manufacturer will refund the cost of such product together with the information the manufacturer has used to determine the amount of the refund; and

 

(f) The text of the statement which the manufacturer will send to the persons specified in § 10823.1(b) informing such persons:

 

(1) That the manufacturer, at his or her expense, will refund the cost of the electronic product plus any transportation costs;

 

(2) Of the amount to be refunded exclusive of transportation costs; and
 

(3) Of the method by which the manufacturer will obtain possession of the product and make the refund.

 

10833.2An assurance that the manufacturer will provide the Secretary with progress reports on the effectiveness of the plan, including the number of refunds made.

authority

Section 19(a)(3) of the District of Columbia Pharmacist and Pharmacy Regulation Act of 1980, effective September 16, 1980 (D.C. Law 3-98; D.C. Official Code § 47-2885.18(a)(3) (2005 Repl.)); Mayor’s Order 98-48, dated April 15, 1998; Section 4902 of the Fiscal Year 2002 Budget Support Act of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official Code § 7-731 (2008 Repl.)); Section 15 of the District of Columbia Medical Device Manufacture and Distribution Licensure Act of 1990, effective June 13, 1990 (D.C. Law 8-137; D.C. Official Code § 48-714(a) (2005 Repl.)); and Mayor’s Order 98-88, dated May 29, 1998.

source

Final Rulemaking published at 60 DCR 10252 (July 12, 2013).